Table 2.

Patient Characteristics and Preoperative Parameters in the TURP Cohort.

Parameter Value
Number of patients 58

Age (y), median (IQR) 52 (49.5–54)

 Min, max 34, 55

Prostate volume (mL), median (IQR) 35 (24.5–56)

PSA (ng/mL), median (IQR) 1.4 (0.65–3.1)
Pre-surgery medical treatment, n (%) 39 (67)
 α-Blocker 35 (60.3)
 5α-Reductase inhibitor 11 (18.9)
 Anti-muscarinic 2 (3.4)

Patient comorbidities based on CCI, n (%)
 CCI: 0–2 46 (79.3)
 CCI: 3–4 10 (17.2)
 CCI: ≥5 2 (3.4)

Preoperative urinary retention status, n (%) 16 (27.6)
 Permanent indwelling catheter 12 (20.7)
 Clean intermittent catheterization 4 (6.9)
Number of preoperative trial of void attempts, median (IQR) 1 (0–2)
Predominant LUTS, n (%)
 Emptying 34 (58.6)
 Storage 20 (34.5)

Pre-TURP flowmetry parameters, median (IQR)
 Voided volume (mL) 224 (179–345)
 Qmax (mL/s) 6.85 (6–10)
 Residual volume (mL) 120 (70–170)

Pressure flow study, n (%) 36 (62)
 Obstructed 24 (41.3)
 Detrusor overactivity 2 (3.44)
 Detrusor underactivity 3 (5.2)
 Stress urinary incontinence 1 (1.7)

CCI, Charlson Comorbidity Index; IQR, interquartile range; LUTS, lower urinary tract symptoms; max, maximum; min, minimum; PSA, prostate-specific antigen; Qmax, maximal flow rate; TURP, transurethral resection of the prostate.

RMMJ Rambam Maimonides Medical Journal Rambam Health Care Campus 2024 April; 15(2): e0006. ISSN: 2076-9172
Published online 2024 April 28. doi: 10.5041/RMMJ.10520